493— The Effects of 5-Azacytidine on HLA-ABC, HLA-E, HLA-G and HLA-A Expression by Hansen, Adam & O\u27Donnell, Robert W
The Effects of 5-Azacytidine on HLA-ABC, HLA-E, HLA-G and HLA-A Expression
Adam Hansen and Dr. Robert O’Donnell 
OBJECTIVE
Investigate the impact of 5-azaC on HLA-




Epigenetic modifiers, like the DNA methylation inhibitor 5-
Azacytidine (5-AzaC), have been shown to increase human
leukocyte antigen (HLA) expression. The expression of
HLA is required for a T-cell response to detect tumor cells.
A lack of HLA expression allows tumor cells to escape
immune detection. It has been previously shown that 5-
AzaC is able to upregulate HLA-ABC expression in the cell
line MDA-MB-435. However, other HLA proteins like HLA-E
and HLA-G may be concurrently upregulated, which would
have negative implications on tumor immunity. One flask of
MDA-MB-435 cells was treated for 48 hours with 5-AzaC at
0.0025 mg/mL and another was left untreated. The cells
were harvested and incubated with control antibodies or
the experimental antibodies, Anti-HLA-ABC, Anti-HLA-G,
and Anti-HLA-E and analyzed via flow cytometry.
Preliminary experiments testing for the expression of HLA-
E and HLA-G have both demonstrated a slight increase in
their expression compared to the untreated cells. Although
minor, the increase in HLA-E and HLA-G expression may
have negative implications on tumor survival and
pathogenesis. Understanding individual HLA upregulation
may prove to be beneficial and applicable to cancer
immunotherapy, an expanding field of improved cancer
treatments.
Fig 1. The mechanism of CpG Island Methylation.
Fig 2. MTT Cytotoxicity analysis of MDA-MB-435 cells with a 
decreasing concentration of 5-AzaC (mg/mL).
DISCUSSION
5-AzaC Concentration
 Low doses of 5-AzaC promote cell survivability (Fig 2.)
Previous Results
 On average, HLA Class I expression of transient absence 
cells increased by 1.57 fold, compared to the control cells 
(Fig 4.)
 HLA Class I expression in the continuously treated cell line 
also increased by a fold of 1.63 compared to the control 
cells (Fig 4.)
Results
 HLA Expression of HLA-E displays clear increases, with an 
increase of 81.69% on average (Table 2.)
 Increases in HLA-E aid cancer cells in evading the 
human immune system 
 HLA-A and HLA-G both suggest an increase in expression, 
however, the values are so low no conclusive remarks can 
be made (Table 2.)
CONCLUSION
 HLA expression remains stable following a one-week and 
two-week absence of 5-AzaC
 5-AzaC may increase HLA-E, a negative impact on the 
human immune system response
 More research must be done to review the impact of 5-
azaC on HLA-A and HLA-G
ACKNOWLEDGEMENTS
I would like to thank Dr. O’Donnell for his constant mentorship 
and guidance at SUNY Geneseo, the other members of the 
O’Donnell lab and the Biology department. We would also like 
to thank the Carl Savino ‘53 endowment fund, the Geneseo 
foundation for research and travel grants and the department 
of biology who have kindly provided funding for lab materials 
and travel. 
REFERENCES
1. Mendonça-Torres, M. C., & Roberts, S. S. (2013). The translocator protein (TSPO) ligand PK11195 induces apoptosis and cell cycle 
arrest and sensitizes to chemotherapy treatment in pre- and post-relapse neuroblastoma cell lines. Cancer Biology & Therapy, 14(4), 
319–326. 
2. Chen, Y., Sajjad, M., Wang, Y., Batt, C., Nabi, H. A., & Pandey, R. K. (2011). TSPO 18 kDa (PBR) Targeted Photosensitizers for 
Cancer Imaging (PET) and PDT. ACS Medicinal Chemistry Letters, 2(2), 136–141
3. Ostuni, M. A., Ducroc, R. , Péranzi, G. , Tonon, M. , Papadopoulos, V. and Lacapere, J. (2007), Translocator protein (18 kDa) ligand 
PK 11195 induces transient mitochondrial Ca2+ release leading to transepithelial Cl− secretion in HT‐29 human colon cancer cells. 
Biology of the Cell, 99: 639-647.
4. Cancer Statistics, 2019 Rebecca L. Siegel, MPH ; Kimberly D. Miller, MPH ; Ahmedin Jemal, DVM, PhD, CA CANCER J CLIN 
2019;0:1–28
INTRODUCTION
In 2020, 100,350 melanomas are expected to be 
diagnosed in the United States
• Estimated death from melanoma in 2019: 6,850 
(CDC)
5-AzaC: nucleoside-based DNA methyltransferase 
inhibitor that induces demethylation and gene 
reactivation
5-AzaC CONCENTRATION
 96 well plate MTT cytotoxicity analysis 
Varying amounts of 5-azaC
0.10 to 0.000198 (mg/mL) 
Cell survivability 
Fig 8. Role of MHC Class I HLA expression .
FUTURE STUDIES
 Further research into the long-term stability of HLA and the 
impact 5-azaC has on HLA-G and HLA-E
PREVIOUS RESULTS
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Mean 239.20 421.49 368.00 375.37
Median 181.06 305.05 266.55 254.83
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Length of Transient Absence
Average Effect of 5-AzaC on HLA Class I Expression
Control Transient Absence Continous
Fig 4. Average increase in HLA-ABC in MDA-MB-435 cells treated with 5-
AzaC. Clear increase between the Control and Experimental groups.
Fig 3. Week 2 Flow Cytometry Fluorescence of HLA-ABC in MDA-MB-435 cells.
Table 2. Flow Cytometry Fluorescence of HLA –A, -E, -G in MDA-MB-435 cells.









HLA-A 4.89 6.45 27.51%
HLA-E 18.22 32.30 81.69%



























Table 1. Flow Cytometry Fluorescence of HLA-ABC in MDA-MB-435 cells.
